| 展会日期 | 2017-03-28 至 2017-03-30 |
| 展出城市 | 上海 |
| 展出地址 | 金茂君悦大酒店 |
| 展馆名称 | 金茂君悦大酒店 |
| 主办单位 | Cambridge Healthtech institute (CHI) |
| 展会日期 | 2017-03-28 至 2017-03-30 |
| 展出城市 | 上海 |
| 展出地址 | 金茂君悦大酒店 |
| 展馆名称 | 金茂君悦大酒店 |
| 主办单位 | Cambridge Healthtech institute (CHI) |
本次峰会的主题有:
Track1:Protein & Antibody Engineer蛋白质与抗体工程
Track2: Protein Aggregation & Stability 蛋白质聚集和稳定性
Track3: Immuno-Oncology 瘤免疫疗法
Track4: Analytical Characterization of Biotherapeutics 生物药物特征分析
| /confirm/iED SPEAKERS (PRELIMINARY AGENDA) |
| Chris Bailey-Kellogg, Ph.D., Professor, Computer Science, University of Dartmouth |
| Frank Bernhard, Ph.D., Lab Manager, Biophysical Chemistry, Goethe University Frankfurt |
| Bo Chen, Ph.D., CEO, Shanghai Junshi |
| Danny Chou, Ph.D., President, Compassion BioSolutions, LLC |
| Shan Chung, Ph.D., Senior Scientist and Group Leader, Bioanalytical Sciences, Genentech |
| Liangpeng Ge, Ph.D., Director, Institute of Bingengineering, Chongqing Academy of Animal Sciences |
| Jinming Gu, Ph.D., Executive Director, Biologics Discovery, Shanghai Hengrui Pharmaceutical Co., Ltd. |
| Chan Hyuk Kim, Ph.D., Assistant Professor, Biological Sciences, KAIST |
| Tomasz Klaus, MSc., Research Assistant, Malopolska Centre of Biotechnology, Jagiellonian University in Krakow |
| Manfred Konrad, Ph.D., Max-Planck Institute for Biophysical Chemistry, Head, Enzyme Biochemistry Laboratory |
| Sunbae Lee, Ph.D., Senior Research Scientist, R&D Center, Alteogen, Inc. |
| Ming Lei, Senior Research Investigator II, Lead Discovery and Optimization, Bristol-Myers Squibb Company |
| Han Li, Ph.D., Principal Scientist, Leads Discovery & Optimization, Bristol-Myers Squibb Company |
| Bertil Lindmark, MD., Ph.D., Chief Medical Officer, ASLAN Pharmaceuticals |
| Hongtao Lu, Ph.D., Executive Vice President & CSO, Discovery, Zai Laboratory |
| Peter Luo, Ph.D., CEO & Co-Founder, Adagene |
| Jennifer McManus, Ph.D., Lecturer, Department of Chemistry, National University of Ireland Maynooth |
| Tatyana Mezhebovsky, Ph.D., Principal Scientist, BioFormulations, Sanofi US |
| Ravish Patel, Ph.D., Scientist, Bioanalytical (Biologics), Analytical Development Lab, EPR Centre for Cancer Research and Bioinformatics Pvt. Ltd. (A Vitane Group of Companies) |
| Xueming Qian, Ph.D., Chairman & CEO, MabSpace Biosciences |
| Christian Schoeneich, Ph.D., Professor and Chair, Pharmaceutical Chemistry, University of Kansas Lawrence |
| Jamshid Tanha, Ph.D., Senior Research Officer, Human Health Therapeutics Portfolio, National Research Council Canada |
| Susumu Uchiyama, Ph.D., Associate Professor, Graduate School of Engineering, Osaka University |
| Chengbin Wu, Ph.D., CEO, Epimab |
| Ting Xu, Ph.D., CEO & President, Alphamab |
| Mark Yang Ph.D., Director of Fill Finish Development, BioPharmaceutical Development, Genzyme |
| Ming Qiang Zhang, Ph.D., Head, R&D, Amgen Asia |
| Aichi Zhao, Ph.D., President, R&D, OriMabs, Ltd. |
| Lei Zheng, Ph.D., Assistant Professor, Oncology and Gastrointestinal Cancer, Johns Hopkins University |
| Eunice Zhou, Ph.D., Associate Adjunct Professor, Anesthesia, UC San Francisco |
| Joy Zhou, Ph.D., Principal Scientist / Associate Director, DP MST, Shire |
| Zhenping Zhu, Ph.D., Executive Vice President, Global Biologics R&D, Kadmon Corp, LLC |
本次峰会的主题有:
Track1:Protein & Antibody Engineer蛋白质与抗体工程
Track2: Protein Aggregation & Stability 蛋白质聚集和稳定性
Track3: Immuno-Oncology 瘤免疫疗法
Track4: Analytical Characterization of Biotherapeutics 生物药物特征分析
| /confirm/iED SPEAKERS (PRELIMINARY AGENDA) |
| Chris Bailey-Kellogg, Ph.D., Professor, Computer Science, University of Dartmouth |
| Frank Bernhard, Ph.D., Lab Manager, Biophysical Chemistry, Goethe University Frankfurt |
| Bo Chen, Ph.D., CEO, Shanghai Junshi |
| Danny Chou, Ph.D., President, Compassion BioSolutions, LLC |
| Shan Chung, Ph.D., Senior Scientist and Group Leader, Bioanalytical Sciences, Genentech |
| Liangpeng Ge, Ph.D., Director, Institute of Bingengineering, Chongqing Academy of Animal Sciences |
| Jinming Gu, Ph.D., Executive Director, Biologics Discovery, Shanghai Hengrui Pharmaceutical Co., Ltd. |
| Chan Hyuk Kim, Ph.D., Assistant Professor, Biological Sciences, KAIST |
| Tomasz Klaus, MSc., Research Assistant, Malopolska Centre of Biotechnology, Jagiellonian University in Krakow |
| Manfred Konrad, Ph.D., Max-Planck Institute for Biophysical Chemistry, Head, Enzyme Biochemistry Laboratory |
| Sunbae Lee, Ph.D., Senior Research Scientist, R&D Center, Alteogen, Inc. |
| Ming Lei, Senior Research Investigator II, Lead Discovery and Optimization, Bristol-Myers Squibb Company |
| Han Li, Ph.D., Principal Scientist, Leads Discovery & Optimization, Bristol-Myers Squibb Company |
| Bertil Lindmark, MD., Ph.D., Chief Medical Officer, ASLAN Pharmaceuticals |
| Hongtao Lu, Ph.D., Executive Vice President & CSO, Discovery, Zai Laboratory |
| Peter Luo, Ph.D., CEO & Co-Founder, Adagene |
| Jennifer McManus, Ph.D., Lecturer, Department of Chemistry, National University of Ireland Maynooth |
| Tatyana Mezhebovsky, Ph.D., Principal Scientist, BioFormulations, Sanofi US |
| Ravish Patel, Ph.D., Scientist, Bioanalytical (Biologics), Analytical Development Lab, EPR Centre for Cancer Research and Bioinformatics Pvt. Ltd. (A Vitane Group of Companies) |
| Xueming Qian, Ph.D., Chairman & CEO, MabSpace Biosciences |
| Christian Schoeneich, Ph.D., Professor and Chair, Pharmaceutical Chemistry, University of Kansas Lawrence |
| Jamshid Tanha, Ph.D., Senior Research Officer, Human Health Therapeutics Portfolio, National Research Council Canada |
| Susumu Uchiyama, Ph.D., Associate Professor, Graduate School of Engineering, Osaka University |
| Chengbin Wu, Ph.D., CEO, Epimab |
| Ting Xu, Ph.D., CEO & President, Alphamab |
| Mark Yang Ph.D., Director of Fill Finish Development, BioPharmaceutical Development, Genzyme |
| Ming Qiang Zhang, Ph.D., Head, R&D, Amgen Asia |
| Aichi Zhao, Ph.D., President, R&D, OriMabs, Ltd. |
| Lei Zheng, Ph.D., Assistant Professor, Oncology and Gastrointestinal Cancer, Johns Hopkins University |
| Eunice Zhou, Ph.D., Associate Adjunct Professor, Anesthesia, UC San Francisco |
| Joy Zhou, Ph.D., Principal Scientist / Associate Director, DP MST, Shire |
| Zhenping Zhu, Ph.D., Executive Vice President, Global Biologics R&D, Kadmon Corp, LLC |